Partek Milestone: Cited in Over 3,000 Peer-reviewed Articles
News Feb 20, 2015
Partek Incorporated has reached a milestone by having its software cited in over three thousand peer-reviewed scientific publications including prestigious publications such as New England Journal of Medicine, Cell, and Nature.
On average that is about two citations per business day in the last five years on topics including drug research, human genetics and disease relationships, causes, diagnosis, and treatments. Samples of scientific papers citing the use of Partek software are listed on the Partek website.
When asked the reason so many researchers have used Partek software in their publications, Donald Meyer, COO for Partek, pointed to their long history in the genomics field as well as the ease of use of their software. “Partek software has been used in the Life Sciences for more than 15 years. We are proud that we have been able to assist scientists in their studies of disease and treatments.”
“All of us at Partek get a great deal of satisfaction knowing that the software we create is being used by scientists to advance the health and well-being of people worldwide,” said Tom Downey, CEO of Partek.
Getting to Know the Microbes that Drive Climate ChangeNews
A new understanding of the microbes and viruses in the thawing permafrost in Sweden may help scientists better predict the pace of climate change.READ MORE
How Many People Die From TB Every Year?News
Discrepancies between the estimates for global tuberculosis deaths is due to different methodologies and data sources used by each institution. The results highlight the need to improve the modeling approaches in these countries in order to understand the true burden of the disease and design adequate health policies.READ MORE
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE